Cardiac microdialysis of salicylic acid .OH generation on nonenzymatic oxidation by norepinephrine in rat heart

Biochem Pharmacol. 1997 May 9;53(9):1375-8. doi: 10.1016/s0006-2952(96)00870-2.

Abstract

The effect of pargyline, a monoamine oxidase inhibitor, on the generation of hydroxyl free radicals (.OH) was investigated using cardiac microdialysis. Salicylic acid in Ringer's solution (0.5 nmol x microL(-1) x min(-1)) was infused directly through a microdialysis probe to detect the generation of .OH as reflected by the formation of dihydroxybenzoic acid (DHBA) in the myocardium of anesthetized rats. When pargyline (100 nmol x microL(-1) x min(-1)) was infused in rat heart, the level of norepinephrine (NE) gradually increased in a time-dependent manner and an increase of DHBA was also observed. When NE was administered to the pargyline pretreated animals, a marked elevation in the levels of 2,3- and 2,5-DHBA formation was obtained, as compared to the group treated with NE only, showing a positive linear correlation between NE and .OH formation trapped as 2,3-DHBA (R2 = 0.981) or 2,5-DHBA (R2 = 0.984) in the dialysate. NE clearly produced an increase in .OH formation. These results indicate that accumulation of NE in the extracellular fluid elicited by pargyline can be auto-oxidized, which in turn, leads (possibly by an indirect mechanism) to the formation of cytotoxic .OH free radicals.

MeSH terms

  • Animals
  • Dose-Response Relationship, Drug
  • Gentisates*
  • Hydroxybenzoates / metabolism
  • Hydroxyl Radical / metabolism*
  • In Vitro Techniques
  • Male
  • Microdialysis
  • Monoamine Oxidase Inhibitors / pharmacology
  • Myocardium / metabolism*
  • Norepinephrine / metabolism*
  • Norepinephrine / pharmacology
  • Pargyline / pharmacology
  • Rats
  • Rats, Wistar
  • Salicylates / pharmacology*
  • Salicylic Acid

Substances

  • Gentisates
  • Hydroxybenzoates
  • Monoamine Oxidase Inhibitors
  • Salicylates
  • Hydroxyl Radical
  • 2,3-dihydroxybenzoic acid
  • Pargyline
  • Salicylic Acid
  • 2,5-dihydroxybenzoic acid
  • Norepinephrine